HomeInsightsPE

Remus Pharmaceuticals Ltd PE Ratio

Remus Pharmaceuticals Ltd PE Ratio

stocks purchased

₹ 0.3 Cr

Volume Transacted

()

stocks purchased

1.4 K

Stocks Traded

()

Last Updated on: Dec 12, 2024

Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

PE

72.4

Last updated on: Dec 12, 2024

Key Highlights

  • The P/E Ratio of Remus Pharmaceuticals Ltd is 72.4 as of 12 Dec 24 .
  • The P/E Ratio of Remus Pharmaceuticals Ltd is 47.2 as of March 2024 .
  • The Latest Trading Price of Remus Pharmaceuticals Ltd is ₹ 2500 as of 12 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.
Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

PE

47.2

Last updated on: Invalid Date

Company Fundamentals for Remus Pharmaceuticals Ltd

No data available

Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

Share Price

₹ 2500

-11.60 (-0.46%)

stock direction

Last updated on: Dec 12, 2024

Market Price of Remus Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Remus Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Dec 20242500
11 Dec 20242511.6
10 Dec 20242556.05
09 Dec 20242587.05
06 Dec 20242571.75
05 Dec 20242566.85
04 Dec 20242624.45
03 Dec 20242640
02 Dec 20242645.05
29 Nov 20242710.5

SWOT Analysis Of Remus Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Remus Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Remus Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Key Valuation Metric of Remus Pharmaceuticals Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Remus Pharmaceuticals Ltd

No data available

* All values are in %

About Remus Pharmaceuticals Ltd

  • Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat.
  • Subsequently, Company converted from a Private to Public and the name of the Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs.
  • It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.
  • The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

Remus Pharmaceuticals Ltd News Hub

News

Remus Pharmaceuticals to convene AGM

Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company w...

Read more

2024-08-31 00:00:00

News

Board of Remus Pharmaceuticals recommends interim dividend

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting ...

Read more

2024-11-09 00:00:00

News

Remus Pharmaceuticals to convene board meeting

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 No...

Read more

2024-11-07 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions